|1.||Briski, Karen P: 3 articles (06/2009 - 07/2006)|
|2.||Kale, Ajay Y: 3 articles (06/2009 - 07/2006)|
|3.||Vavaiya, Kamlesh V: 2 articles (06/2009 - 07/2006)|
|4.||Paranjape, Sachin A: 1 article (11/2006)|
|5.||Paranjape, S A: 1 article (06/2006)|
|6.||Briski, K P: 1 article (06/2006)|
|7.||Kale, A Y: 1 article (06/2006)|
|1.||Hypoglycemia (Reactive Hypoglycemia)
11/01/2006 - "Icv administration of CP-472555 during antecedent hypoglycemia prevented RIIH-associated reductions in Fos expression by these neurons. "
07/31/2006 - "Icv CP-472555 administration prior to antecedent hypoglycemia prevented RIIH-associated increases in GR mRNA in each of these sites. "
06/30/2006 - "The present studies utilized the selective, nonsteroidal glucocorticoid receptor antagonist, CP-472555, as a pharmacological tool to investigate the hypothesis that hypoglycemic hypercorticosteronemia modulates CNS efferent autonomic and neuroendocrine motor responses to recurring insulin-induced hypoglycemia via glucocorticoid receptor-dependent mechanisms. "
06/30/2006 - "I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration."
06/01/2009 - "Bilateral administration of the selective GR antagonist, CP-472555, into the PVN prior to the first three NPH injections prevented amplification of hypoglycemia in response to the final insulin dose, while intra-PVN delivery of the GR agonist, dexamethasone, to euglycemic rats did not modify ensuing NPH-induced hypoglycemia. "
|2.||Glucocorticoid Receptors (Glucocorticoid Receptor)
|3.||Messenger RNA (mRNA)